Faecal immunochemical test-based colorectal cancer screening programme SVIT in Slovenia: Pilot phase

European Journal of Cancer Prevention

Volumn 23, Issue 4, 2014, Pages 235-239

  Tepeš, Bojan ^a   Štabuc, Borut ^b   Stefanovič, Milan ^a   Bračko, Matej ^c   Frkovič Grazio, Snežana ^c   Novak Mlakar, Dominika ^d   Maučec Zakotnik, Jožica ^d  

^a AM DC Rogaska ^*  (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c INSTITUTE OF ONCOLOGY   (Slovenia)

^d NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

Author keywords

colorectal cancer; faecal immunochemical test; pilot phase; screening programme

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CECUM; CLASSIFICATION ALGORITHM; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; DIAGNOSTIC TEST ACCURACY STUDY; DIGESTIVE TRACT INTUBATION; FECAL IMMUNOCHEMICAL TEST; FEMALE; HEALTH PROGRAM; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; OUTCOME ASSESSMENT; PILOT STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING TEST; SEX DIFFERENCE; SLOVENIA; SURVIVAL RATE; TUMOR DIAGNOSIS; ADENOMA; CARCINOMA; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; MIDDLE AGED; PATHOLOGY; PROCEDURES;

ADENOMA; AGED; CARCINOMA; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; OCCULT BLOOD; PILOT PROJECTS; SLOVENIA;

EID: 84902073858     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283651c9e     Document Type: Article

References (28)

1. Allison JE, Tekawa IS, Ransom LJ, Adrain AL (1999). A comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med 334: 155-159
2. Caligiore P, St Macrae FA, John DJ (1982). Peroxidase levels in food: Relevance to colorectal cancer screening. Am J Clin Nutr 35:1487-1489. (Pubitemid 12024979)
3. Castiglione G, Zappa M, Grazzini G, Mazzotta A, Biagini M, Salvadori P, et al. (1996). Immunochemical vs guaiac faecal occult blood tests in a populationbased screening programme for colorectal cancer. Br J Cancer 74:141-144. (Pubitemid 26231992)
4. Denis B, Ruetsch M, Strentz P, Vogel JY, Guth F, Boyaval JM, et al. (2004). Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. BMJ 329:133-135
5. Dé sirée L (2007). Colorectal cancer screening improved with immunochemical fecal occult blood test. Ann Intern Med 146:244-255
6. Guittet L, Bouvier V, Mariotte N, Vallee JP, Levillain R, Tichet J, Launoy G (2009). Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location. Br J Cancer 100:1230-1235
7. Halloran S, Launoy G, Zappa M (2010). Faecal occult blood testing. In: Segnan N, Patnick J, von Karsa L. International Agency for Research on Cancer, editors. European Guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Publications Office of the European Union. pp. 103-144
8. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. (1996). Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348:1472-1477
9. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Cochrane Library (2008). Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 24:CD001216
10. Hundt S, Haug U, Brenner H (2009). Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 150:162-169
11. Jørgensen OD, Kronborg O, Fenger C (2002). A randomised study of screening for colorectal cancer using faecal occult blood testing: Results after 13 years and seven biennial screening rounds. Gut 50:29-32
12. Ko CW, Dominitz JA, Nguyen TD (2003). Fecal occult blood testing in a general medical clinic: Comparison between guaiac-based and immunochemicalbased tests. Am J Med 115:111-114. (Pubitemid 37288838)
13. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sandergaard O (1996). Randomised study of screening for colorectal cancer with faecal-occultblood. Lancet 348:1467-1471
14. Lansdorp-Vogelaar I, Knudsen AB, Brenner H (2011). Costeffectiveness of colorectal cancer screening. Epidemiol Rev 33:88-100
15. Logan RFA, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C (2012). Outcomes of the bowel cancer screening programme (BCSP) in England after the first 1 million tests. Gut 61:1439-1446
16. Mandel JS, Church TR, Ederer F, Bond JH (1999). Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91:434-437. (Pubitemid 29128279)
17. Martinez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E,Winawer SJ, et al. (2009). A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 136:832-841
18. Primic-Zakelj M, Bracko M, Hocevar M, Krajc M, Pompe-Kirn V, Strojan P, et al. (2012). Cancer in Slovenia 2008. National Cancer Registry. Ljubljana, Slovenia: Institute for Oncology
19. Rex DK, Bond JH, Winawer S, Levin TR, Burt RW, Johnson DA, et al. (2002). Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: Recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 97: 1296-1308
20. Rozen P, Knaani J, Samuel Z (2000). Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study. Cancer 89:46-52
21. Scholefield JH, Moss S, Sufi F, Mandham C, Hardcastle JD (2002). Effect of faecal occult blood screening on mortality from colorectal cancer: Results from a randomised controlled trial. Gut 50:840-844
22. Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD (2012). Nottingham trial of faecal occult blood testing for colorectal cancer: A 20-year follow-up. Gut 61:1036-1040
23. Segnan N, Patnick J, von Karsa L. International Agency for Research on Cancer (2010). European Guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Publications Office of the European Union. pp. 103-144
24. Smith A, Young GP, Cole SR, Bampton P (2006). Comparison of a brushsampling fecal immunochemical test for hemoglobin with a sensitive guaiacbased fecal occult blood test in detection of colorectal neoplasia. Cancer 107:2152-2159
25. Van Rossum LG, van Rijn AF, Laheij RJ, Laheij RJ, van Oijen MG, Fockens P, et al. (2008). Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135:82-90
26. Yamai Y, Mitsushima T, Ikuma H,Watanabe H, Okamoto M,Wada R, et al. (2004). Incidence and recurrence rates of colorectal adenomas estimated by annually repeated colonoscopies on asymptomatic Japanese. Gut 53:568-572
27. Zappa M, Castiglione G, Paci E, Grazzini G, Rubeca T, Turco P, et al. (2001). Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: The District of Florence experience. Int J Cancer 92:151-154. (Pubitemid 32187045)
28. Zorzi M, Barca A, Falcini F, Grazzini G, Pizzuti R, Ravaioli A, et al. (2007). Screening for colorectal cancer in Italy: 2005 survey. Epidemiol Prev 31 (Suppl 2):49-60